The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”), a commercial-stage international biopharmaceutical company focused on cannabinoid-based medicines, is pleased to announce that Aras Azadian, CEO of Avicanna Inc will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026.
asserted
Azadian → invite → 17th
The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time.
asserted
event → conduct → time
Avicanna’s CEO Aras Azadian will be presenting on Sep 17trh at 10:30 am Eastern Time.
asserted
CEO → present → am
A re-play of the webcast will be available following the conclusion of the conference.
asserted
play → follow → conference
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
asserted
investors → recommend → updates
About Avicanna Inc
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments.
asserted
Avicanna → focus → segments
Avicanna has an established scientific platform including R&D and clinical development leading to the commercialization of more than thirty proprietary, evidence-based finished products and supporting four commercial stage business pillars.
asserted
Avicanna → have → pillars
- Medical Cannabis formulary (RHO Phyto™): The formulary offers a diverse range of proprietary products including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids, supported by ongoing patient and medical community education.
asserted
formulary → offer → education
RHO Phyto is an established brand in Canada currently available nationwide across several channels and expanding into new international markets.
asserted
Phyto → establish → markets
MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the medical cannabis patients’ journey.
asserted
MyMedi.ca → form → journey
MyMedi.ca is operated by Northern Green Canada Inc. and features a diverse portfolio of products and bilingual pharmacist-led patient support programs.
asserted
MyMedi.ca → operate → products
MyMedi.ca also provides specialty services to distinct patient groups such as veterans and collaborates with public and private payers for adjudication and reimbursement.
asserted
MyMedi.ca → provide → adjudication
MyMedi.ca provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens.
asserted
MyMedi.ca → provide → regimens
- Pharmaceutical pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development.
asserted
that → leverage → development
These cannabinoid-based candidates aim to address unmet needs in the areas of dermatology, chronic pain, and various neurological disorders.
asserted
candidates → base → dermatology
- Active pharmaceutical ingredients (Aureus Santa Marta™): Active pharmaceutical ingredients supplied by the Company’s majority owned subsidiary Santa Marta Golden Hemp SAS (“SMGH”) is a commercial-stage business dedicated to providing various forms of high-quality CBD, THC and CBG to the Company’s international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.
asserted
ingredients → supply → food
SMGH also forms part of the Company’s supply chain and is a source of reliable input products for its consumer retail, medical cannabis, and pharmaceutical products globally.
asserted
SMGH → form → consumer
This news release contains “forward-looking information” within the meaning of applicable securities laws.
asserted
release → contain → laws
Forward-looking information contained in this news release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions.
uncertain
information → look → may
Forward-looking information contained in this news release includes, without limitation, statements with respect to the Company’s future business operations, the opinions or beliefs of management and future business goals.
asserted
information → look → management
Although the Company believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct.
asserted
they → believe → assurance
Actual results and developments may differ materially from those contemplated by these statements.
uncertain
results → differ → statements
Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information.
uncertain
events → look → information
Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated March 31, 2026, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR+ at www.sedarplus.ca.
asserted
risks → include → www.sedarplus.ca
The statements in this news release are made as of the date of this release.
asserted
statements → make → release
The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
asserted
Company → disclaim → laws
The Aporia
